Cargando…
Targeting focal adhesion turnover in invasive breast cancer cells by the purine derivative reversine
BACKGROUND: The dynamics of focal adhesion (FA) turnover is a key determinant for the regulation of cancer cell migration. Here we investigated FA turnover in a panel of breast cancer models with distinct invasive properties and evaluated the impact of reversine on this turnover in relation to cance...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3844920/ https://www.ncbi.nlm.nih.gov/pubmed/24169345 http://dx.doi.org/10.1038/bjc.2013.675 |
_version_ | 1782293263976235008 |
---|---|
author | Bijian, K Lougheed, C Su, J Xu, B Yu, H Wu, J H Riccio, K Alaoui-Jamali, M A |
author_facet | Bijian, K Lougheed, C Su, J Xu, B Yu, H Wu, J H Riccio, K Alaoui-Jamali, M A |
author_sort | Bijian, K |
collection | PubMed |
description | BACKGROUND: The dynamics of focal adhesion (FA) turnover is a key determinant for the regulation of cancer cell migration. Here we investigated FA turnover in a panel of breast cancer models with distinct invasive properties and evaluated the impact of reversine on this turnover in relation to cancer cell invasion in in vitro and in vivo conditions. METHODS: Live imaging and immunofluorescence assays were used to investigate FA turnover in breast cancer cells. Biochemical studies were used to investigate the impact of reversine on FA signalling and turnover. In vivo activity was investigated using orthotopic breast cancer mouse models. RESULTS: Accelerated FA disassembly from plasma membrane protrusions was observed in invasive compared with non-invasive breast cancer cells or non-immortalised mammary epithelial cells. Reversine significantly inhibited FA disassembly leading to stable FAs, which was associated with reduced cell motility and invasion. The inhibitory effect of reversine on FA turnover accounted for a large part on its capacity to interfere with FAK function on regulating its downstream targets. In orthotopic breast cancer mouse models, reversine revealed a potent inhibitory activity on tumour progression to metastasis. CONCLUSION: These results support the utility of targeting FA turnover as a therapeutic approach for invasive breast cancer. |
format | Online Article Text |
id | pubmed-3844920 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-38449202014-11-26 Targeting focal adhesion turnover in invasive breast cancer cells by the purine derivative reversine Bijian, K Lougheed, C Su, J Xu, B Yu, H Wu, J H Riccio, K Alaoui-Jamali, M A Br J Cancer Translational Therapeutics BACKGROUND: The dynamics of focal adhesion (FA) turnover is a key determinant for the regulation of cancer cell migration. Here we investigated FA turnover in a panel of breast cancer models with distinct invasive properties and evaluated the impact of reversine on this turnover in relation to cancer cell invasion in in vitro and in vivo conditions. METHODS: Live imaging and immunofluorescence assays were used to investigate FA turnover in breast cancer cells. Biochemical studies were used to investigate the impact of reversine on FA signalling and turnover. In vivo activity was investigated using orthotopic breast cancer mouse models. RESULTS: Accelerated FA disassembly from plasma membrane protrusions was observed in invasive compared with non-invasive breast cancer cells or non-immortalised mammary epithelial cells. Reversine significantly inhibited FA disassembly leading to stable FAs, which was associated with reduced cell motility and invasion. The inhibitory effect of reversine on FA turnover accounted for a large part on its capacity to interfere with FAK function on regulating its downstream targets. In orthotopic breast cancer mouse models, reversine revealed a potent inhibitory activity on tumour progression to metastasis. CONCLUSION: These results support the utility of targeting FA turnover as a therapeutic approach for invasive breast cancer. Nature Publishing Group 2013-11-26 2013-10-29 /pmc/articles/PMC3844920/ /pubmed/24169345 http://dx.doi.org/10.1038/bjc.2013.675 Text en Copyright © 2013 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/3.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ |
spellingShingle | Translational Therapeutics Bijian, K Lougheed, C Su, J Xu, B Yu, H Wu, J H Riccio, K Alaoui-Jamali, M A Targeting focal adhesion turnover in invasive breast cancer cells by the purine derivative reversine |
title | Targeting focal adhesion turnover in invasive breast cancer cells by the purine derivative reversine |
title_full | Targeting focal adhesion turnover in invasive breast cancer cells by the purine derivative reversine |
title_fullStr | Targeting focal adhesion turnover in invasive breast cancer cells by the purine derivative reversine |
title_full_unstemmed | Targeting focal adhesion turnover in invasive breast cancer cells by the purine derivative reversine |
title_short | Targeting focal adhesion turnover in invasive breast cancer cells by the purine derivative reversine |
title_sort | targeting focal adhesion turnover in invasive breast cancer cells by the purine derivative reversine |
topic | Translational Therapeutics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3844920/ https://www.ncbi.nlm.nih.gov/pubmed/24169345 http://dx.doi.org/10.1038/bjc.2013.675 |
work_keys_str_mv | AT bijiank targetingfocaladhesionturnoverininvasivebreastcancercellsbythepurinederivativereversine AT lougheedc targetingfocaladhesionturnoverininvasivebreastcancercellsbythepurinederivativereversine AT suj targetingfocaladhesionturnoverininvasivebreastcancercellsbythepurinederivativereversine AT xub targetingfocaladhesionturnoverininvasivebreastcancercellsbythepurinederivativereversine AT yuh targetingfocaladhesionturnoverininvasivebreastcancercellsbythepurinederivativereversine AT wujh targetingfocaladhesionturnoverininvasivebreastcancercellsbythepurinederivativereversine AT ricciok targetingfocaladhesionturnoverininvasivebreastcancercellsbythepurinederivativereversine AT alaouijamalima targetingfocaladhesionturnoverininvasivebreastcancercellsbythepurinederivativereversine |